...
首页> 外文期刊>Computers and Electrical Engineering >Ontology-driven advanced drug-drug interaction
【24h】

Ontology-driven advanced drug-drug interaction

机译:本体论推动的先进药物 - 药物互动

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The rapid growth of data in the pharmaceutical area has created new challenges for large-scale data mining like Drug-Drug Interaction (DDI) analysis. To meet these challenges, various types of data related to DDI must be integrated with true semantics. However, the existing tools do not provide automated DDI analysis. Interaction details are not machine readable and pharmacists need to do further processing for its extraction. This research paper proposed an ontology-driven Advanced Drug-Drug Interaction (ADDI) system to assists the physicians and pharmacists to identify the DDI effects. ADDI provides ontological definitions and semantic relations among diseases, drugs, ingredients, action mechanism, physiologic effect, dosage formation, administration methods, DDI mechanism, DDI types (Antagonism, Synergism, Potentiation, and Interaction with metabolism), DDI reactions, their frequency and duration. It can be used as Semantic Information Layer (SIL) to resolve the heterogeneity problem and can play a significant role to remove the barriers for semantic interoperability. (C) 2020 Elsevier Ltd. All rights reserved.
机译:制药地区数据的快速增长为药物 - 药物相互作用(DDI)分析等大规模数据挖掘产生了新的挑战。为满足这些挑战,必须与DDI相关的各种类型数据与真正的语义集成。但是,现有工具不提供自动化DDI分析。互动细节不是机器可读性,药剂师需要进一步处理其提取。本研究论文提出了一种本体论推动的先进药物 - 药物互动(ADDI)系统,以帮助医生和药剂师识别DDI效应。 ADDI提供疾病,药物,成分,动作机制,生理学作用,剂量形成,给药方法,DDI机制,DDI类型(对拮抗作用,促性和代谢相互作用),DDI反应,频率和频率的语义关系期间。它可以用作语义信息层(SIL)来解决异质性问题,并且可以发挥重要作用以除去语义互操作性的障碍。 (c)2020 elestvier有限公司保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号